258830 — Sejong Medical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Sejong Medical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	15,098	17,241	16,083	17,992	18,952
Cost of Revenue
Gross Profit	7,880	7,902	8,188	8,573	8,577
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	16,169	20,415	22,188	28,328	33,712
Operating Profit	-1,071	-3,174	-6,105	-10,337	-14,760
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-115	-5,813	-91,272	-26,513	-71,006
Provision for Income Taxes
Net Income After Taxes	455	-6,370	-91,491	-23,826	-72,032
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	470	-5,192	-91,982	-23,826	-72,032
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	470	-5,192	-91,982	-23,826	-72,032
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	25.7	-142	-2,073	-281	-1,127
Dividends per Share